logo

iStock Rating

C
Details...
Enter Symbol click to research

Amgen Inc. (NASDAQ: AMGN)

Sector: Medical

Current Price : $104.24

52 Week Low
$67.1352 Week High
$111.57
 

AMGEN INC(NSDQ:AMGN)
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science''s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people''s lives.
# Employees: 18000
Address: ONE AMGEN CENTER DRIVE,THOUSAND OAKS,CA,USA
Phone: 805-447-1000
Fax: 805-447-1010
Website: www.amgen.com
Email: investor.relations@amgen.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Robert A. Bradway (Chairman of the Board; President and C.E.O.)
Jonathan M. Peacock (Executive Vice President and C.F.O.)
Thomas J.W. Dittrich (Vice President Finance and C.A.O.)
David Baltimore (Director)
Frank J. Biondi (Jr. ,Director,)
Dividend
Ex-Dividend Date: 2/11/2013
Annual Dividend: $1.88
Current Dividend Yield: $1.69
Dividend Paid (3 months): $0.47
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 4/23/2013
Mean EPS (Next Qtr): $1.70
Mean EPS (Year): $7.10
Mean Estimate(Long Term): $9.33
P/E Ratio(Based on EPS estimate): 15.680
Number of Estimates: 5
Shares Performance
Period amgn Compare to S&P
YTD 29.21 % 18.49 %
4 Weeks 15.35 % 15.47 %
12 Weeks 33.52 % 29.03 %
Shares Information
Analyst Coverage: Y
Avg Volume: 4080522
Shares Outstanding: 748M
Market Cap: $83.36B
52 Week High: $111.57
52 Week Low: $67.13
P/E Ratio: 17.220
PEG Ratio: 1.680
Split: On 11/22/1999 amgn split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -16.77 %
EPS Growth in Last Year: 16.81 %
Sales Growth in Last Quarter: 2.36 %
Sales Growth in Last Quarter: 11.28 %
Financials
Qtr Book Value: $4.48
Cash Flow/Share: $13.87
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.